Deng, S., Deng, R., Wang, J., Hu, Q., Xu, B., Zheng, J., . . . Zuo, C. Interferon-α and thymosin-α1 plus tislelizumab enhance CD8+ T cell cytotoxicity toward pancreatic ductal adenocarcinoma. Elsevier.
Chicago Style (17th ed.) CitationDeng, Shun, et al. Interferon-α and Thymosin-α1 Plus Tislelizumab Enhance CD8+ T Cell Cytotoxicity Toward Pancreatic Ductal Adenocarcinoma. Elsevier.
MLA (9th ed.) CitationDeng, Shun, et al. Interferon-α and Thymosin-α1 Plus Tislelizumab Enhance CD8+ T Cell Cytotoxicity Toward Pancreatic Ductal Adenocarcinoma. Elsevier.
Warning: These citations may not always be 100% accurate.